About this trial
Photobiomodulation Group (Intervention Group):
Before the intervention, the patient's skin sensitivity to light will be tested by applying light for 3 minutes to one-fourth of the forearm skin. If redness occurs and persists for more than 2 hours, this indicates photosensitivity, and the intervention will not be performed.
The Patient Information Form will be completed during the first meeting with the patients included in the study. Subsequently, blood values will be determined, the Patient Assessment Form will be filled out, vital signs will be measured, and then the intervention will begin. After routine wound care/cleaning procedures in the intensive care unit, without applying any medication, cream, or lotion to the wound area, red light (660 nm wavelength) will be applied to the wound area for 5 minutes at a distance of 55 cm during the first 3 days, and for 10 minutes at the same distance on the following days. This application will continue once daily for 14 days. Wound assessments will be performed, and photographs will be taken on Day 1, Day 4, Day 7, and Day 14 (Baracho et al., 2021; Viecelli et al., 2024; Lima et al., 2020).
Control Group:
The Patient Information Form will be completed during the first meeting with the patients included in the study. Subsequently, blood values will be determined, the Patient Assessment Form will be filled out, and vital signs will be measured. No intervention will be performed other than the routine wound care procedure carried out in the intensive care unit. Wound assessments will be performed, and photographs will be taken on Day 1, Day 4, Day 7, and Day 14, in the same manner as in the intervention group.
Eligibility criteria
Qualifiers
Patients with Stage II pressure ulcers
Patients without any skin disease
Patients with albumin, platelet, and blood glucose levels within normal ranges
Patients who will stay in the intensive care unit for 14 days or longer
Disqualifiers
Patients who do not consent to participate in the study
Patients with severe nutritional problems and those who are cachectic
Patients with severe edema (+4 or above)
Patients with diabetes mellitus
Trial design
Treatments tested in this trial
- photobiomodulation
Treatment groups
Locations
Sponsors and collaborators
Ankara Medipol University
Lead sponsor
Fenerbahce University
Collaborator
Dr. Lutfi Kirdar Kartal Training and Research Hospital
Collaborator